Nordic Bone
ABOUT USINVESTORSPIPELINENEWSCAREERSCONTACT

November 26, 2007

Osteologix to Present at Lazard Capital Markets 4th Annual Healthcare Conference

November 5, 2007

Osteologix Announces Positive Phase II Study of Its Investigational Osteoporosis Drug, NB S101

Trial Meets Primary Endpoint

November 1, 2007

Osteologix Executive to Present at 6th Annual Partnerships in Clinical Trials Congress and Exhibition 2007

October 30, 2007

Osteologix to Present at the Acumen BioFin Rodman and Renshaw 9th Annual Healthcare Conference

October 24, 2007

Osteologix CEO to Present at Eye for Pharma Early Commercialization, Lifecycle and Portfolio Management Congress 2007

October 8, 2007

Osteologix to Present at BIO Investor Forum; Webcast: October 10, 2007

September 28, 2007

Osteologix to Present at NASDAQ MarketSite during EQUITIES 2007 Transatlantic Conference

September 19, 2007

Osteologix Presents Positive Osteoporosis Drug Data to International Audience of Physicians

Data Demonstrates the Improved Strontium Bioavailability of NB S101 to Strontium Ranelate

July 10, 2007

Osteologix to Present at C.E. Unterberg, Towbin Emerging Opportunities Growth Conference